Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

Salim Yusuf, Kok Lay Teo, Craig S Anderson, J Pogue, L Dyal, I Copland, H Schumacher, G Dagenais, P Sleight, Christopher Bladin

Research output: Contribution to journalArticleResearchpeer-review

776 Citations (Scopus)
Original languageEnglish
Pages (from-to)1174 - 1183
Number of pages10
JournalThe Lancet
Volume372
Issue number9644
Publication statusPublished - 2008

Cite this